Atlas Trials

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Clinical trial NCT01467700 · TERMINATED

Trial details

NCT number
NCT01467700
Sponsor
Takeda
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Depressive Episode
Start date
2011-12-01
Primary completion
2015-03-01
Enrollment
490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.